Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting

被引：8

作者：

Hahr, Allison J.

Molitch, Mark E.

机构：

[1] Division of Endocrinology Metabolism and Molecular Medicine, Northwestern University Feinberg, School of Medicine, Chicago, IL

来源：

DM DISEASE-A-MONTH | 2010年 / 56卷 / 03期

关键词：

GLARGINE HOE 901; IMPROVED GLYCEMIC CONTROL; BLOOD-GLUCOSE CONTROL; TIME-ACTION PROFILE; TO-TARGET TRIAL; NPH INSULIN; BASAL INSULIN; POSTPRANDIAL HYPERGLYCEMIA; SUBCUTANEOUS INJECTION; ANALOG GLARGINE;

D O I：

10.1016/j.disamonth.2009.12.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Management of type 1 and type 2 diabetes is continually evolving, and among these evolving therapies is administration of insulin in its various forms. The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain.

引用

页码：148 / 162

页数：15

共 53 条

[1]

American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS15

[2] Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment [J].

Anderson, JH ;

Brunelle, RL ;

Koivisto, VA ;

Pfutzner, A ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R ;

Bowen, KM ;

Cameron, DP ;

Nankervis, AJ ;

Roberts, AP ;

Zimmet, P ;

Borkenstein, MH ;

Schernthaner, G ;

Waldhausl, WK ;

DeLeeuw, IH ;

Fery, F ;

Scheen, A ;

Somers, G ;

Fettes, IM ;

Tildesley, HD ;

Toth, EL ;

Viikari, J ;

Altman, JJ ;

Bougneres, PF ;

Drouin, P ;

Fossati, P ;

Guillausseau, PJ ;

Marechaud, E ;

Riou, JP ;

Selam, JL ;

Vialettes, PB ;

Beyer, J ;

Federlin, K ;

Fussganger, RD ;

Gries, FA ;

Jastram, HU ;

Koop, I ;

Landgraf, R ;

Rosak, C ;

Schatz, H ;

SchulzeSchleppinghoff, B ;

Seif, FJ ;

Stoeckmann, F ;

Karasik, A ;

Weitzman, S ;

Andreani, D ;

Bompiani, G ;

Crepaldi, G ;

Giorgino, R .

DIABETES, 1997, 46 (02) :265-270

[3] Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes [J].

Ashwell, SG ;

Amiel, SA ;

Bilous, RW ;

Dashora, U ;

Heller, SR ;

Hepburn, DA ;

Shutler, SD ;

Stephens, JW ;

Home, PD .

DIABETIC MEDICINE, 2006, 23 (03) :285-292

[4] Insulin pump therapy in the 21st century - Strategies for successful use in adults, adolescents, and children with diabetes [J].

Bode, BW ;

Tamborlane, WV ;

Davidson, PC .

POSTGRADUATE MEDICINE, 2002, 111 (05) :69-77

[5] Meta-analysis: Efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus [J].

Ceglia, Lisa ;

Lau, Joseph ;

Pittas, Anastassios G. .

ANNALS OF INTERNAL MEDICINE, 2006, 145 (09) :665-675

[6] The use of U-500 in patients with extreme insulin resistance [J].

Cochran, E ;

Musso, C ;

Gorden, P .

DIABETES CARE, 2005, 28 (05) :1240-1244

[7]

DAVIDSON PC, 1995, INSULIN PUMP THERAPY, P59

[8] Pharmacologic therapy for type 2 diabetes mellitus [J].

DeFronzo, RA .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) :281-303

[9] Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control - A randomized, controlled trial [J].

Fanelli, CG ;

Pampanelli, S ;

Porcellati, F ;

Rossetti, P ;

Brunetti, P ;

Bolli, GB .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (07) :504-514

[10] Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes [J].

Feinglos, MN ;

Thacker, CH ;

English, J ;

Bethel, MA ;

Lane, JD .

DIABETES CARE, 1997, 20 (10) :1539-1542

← 1 2 3 4 5 6 →